Literature DB >> 23439656

Integrating dietary supplements into cancer care.

Moshe Frenkel1, Donald I Abrams, Elena J Ladas, Gary Deng, Mary Hardy, Jillian L Capodice, Mary F Winegardner, J K Gubili, K Simon Yeung, Heidi Kussmann, Keith I Block.   

Abstract

Many studies confirm that a majority of patients undergoing cancer therapy use self-selected forms of complementary therapies, mainly dietary supplements. Unfortunately, patients often do not report their use of supplements to their providers. The failure of physicians to communicate effectively with patients on this use may result in a loss of trust within the therapeutic relationship and in the selection by patients of harmful, useless, or ineffective and costly nonconventional therapies when effective integrative interventions may exist. Poor communication may also lead to diminishment of patient autonomy and self-efficacy and thereby interfere with the healing response. To be open to the patient's perspective, and sensitive to his or her need for autonomy and empowerment, physicians may need a shift in their own perspectives. Perhaps the optimal approach is to discuss both the facts and the uncertainty with the patient, in order to reach a mutually informed decision. Today's informed patients truly value physicians who appreciate them as equal participants in making their own health care choices. To reach a mutually informed decision about the use of these supplements, the Clinical Practice Committee of The Society of Integrative Oncology undertook the challenge of providing basic information to physicians who wish to discuss these issues with their patients. A list of leading supplements that have the best suggestions of benefit was constructed by leading researchers and clinicians who have experience in using these supplements. This list includes curcumin, glutamine, vitamin D, Maitake mushrooms, fish oil, green tea, milk thistle, Astragalus, melatonin, and probiotics. The list includes basic information on each supplement, such as evidence on effectiveness and clinical trials, adverse effects, and interactions with medications. The information was constructed to provide an up-to-date base of knowledge, so that physicians and other health care providers would be aware of the supplements and be able to discuss realistic expectations and potential benefits and risks.

Entities:  

Keywords:  cancer care; complementary medicine; dietary supplements; herbal medicine; integrative medicine; nutritional supplements; vitamins

Mesh:

Substances:

Year:  2013        PMID: 23439656     DOI: 10.1177/1534735412473642

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  11 in total

Review 1.  Modification in the diet can induce beneficial effects against breast cancer.

Authors:  Felix Aragón; Gabriela Perdigón; Alejandra de Moreno de LeBlanc
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 2.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

3.  Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.

Authors:  Joshua Bauml; Corey J Langer; Tracey Evans; Sheila N Garland; Krupali Desai; Jun J Mao
Journal:  Support Care Cancer       Date:  2014-04-09       Impact factor: 3.603

4.  The use of dietary supplements in oncology.

Authors:  Moshe Frenkel; Victor Sierpina
Journal:  Curr Oncol Rep       Date:  2014-11       Impact factor: 5.075

5.  Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes.

Authors:  Maja Tank; Kristina Franz; Emanuele Cereda; Kristina Norman
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-06       Impact factor: 4.553

6.  The Circadian System and Cancer: It's About Time!

Authors:  Keith I Block
Journal:  Integr Cancer Ther       Date:  2018-03       Impact factor: 3.279

Review 7.  B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine.

Authors:  Paola Rossi; Raffaele Difrancia; Vincenzo Quagliariello; Elena Savino; Paolo Tralongo; Cinzia Lucia Randazzo; Massimiliano Berretta
Journal:  Oncotarget       Date:  2018-05-15

8.  Open to Exploration? Association of Personality Factors With Complementary Therapy Use After Breast Cancer Treatment.

Authors:  Kirsti I Toivonen; Rie Tamagawa; Michael Speca; Joanne Stephen; Linda E Carlson
Journal:  Integr Cancer Ther       Date:  2018-01-24       Impact factor: 3.279

9.  Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.

Authors:  Mégane Jermini; Julie Dubois; Pierre-Yves Rodondi; Khalil Zaman; Thierry Buclin; Chantal Csajka; Angela Orcurto; Laura E Rothuizen
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

Review 10.  Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE).

Authors:  Riccardo Caccialanza; Paolo Pedrazzoli; Emanuele Cereda; Cecilia Gavazzi; Carmine Pinto; Agostino Paccagnella; Giordano Domenico Beretta; Mariateresa Nardi; Alessandro Laviano; Vittorina Zagonel
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.